The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Latest Articles

Published online
doi:10.1084/jem.2055iti1
The Journal of Experimental Medicine
The Rockefeller University Press, 0022-1007 $30.00
This Article
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
In This Issue

Weakening HIV

HIV levels are lower in patients infected with viruses carrying 5 HLA B–associated Gag mutations.

One person’s fight against an HIV infection can decrease the virus’s ability to threaten its next victim, say Goepfert et al. Mutations that help the virus survive in one host decrease its ability to replicate in the next.

HIV mutations that help the virus bypass the host’s immune system often fall within gag. This gene is a favorite target for mutations because, for some reason, Gag epitopes that are presented by HLA B alleles create the most productive immune response. But Gag is also critical for viral replication. The infected individual doesn’t benefit from replication-dampening gag mutations, as the virus still escapes from cytotoxic T cells.

Goepfert and colleagues now find, however, that the resulting decreased replication may benefit the patient’s sexual partner. Their study of 114 couples found that individuals who were infected by partners with certain HLA B alleles had much lower viral levels when more than five gag mutations were present. Viral levels were lowest in newly infected individuals who did not have the same type of HLA B alleles as their partners, perhaps because the recipients’ T cells efficiently targeted non-Gag epitopes of the mutated virus.

At least five gag mutations were needed to reduce viral load significantly. This threshold might explain why a T cell vaccine that induces immune responses against two Gag epitopes failed in a recent trial. Better results might be gained by targeting more epitopes.

Hema Bashyam

hbashyam{at}rockefeller.edu



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search